Literature DB >> 32101725

Glioblastoma Stem Cells: Driving Resilience through Chaos.

Briana C Prager1, Shruti Bhargava2, Vaidehi Mahadev3, Christopher G Hubert4, Jeremy N Rich5.   

Abstract

Glioblastoma is an aggressive and heterogeneous tumor in which glioblastoma stem cells (GSCs) are at the apex of an entropic hierarchy and impart devastating therapy resistance. The high entropy of GSCs is driven by a permissive epigenetic landscape and a mutational landscape that revokes crucial cellular checkpoints. The GSC population encompasses a complex array of diverse microstates that are defined and maintained by a wide variety of attractors including the complex tumor ecosystem and therapeutic intervention. Constant dynamic transcriptional fluctuations result in a highly adaptable and heterogeneous entity primed for therapy evasion and survival. Analyzing the transcriptional, epigenetic, and metabolic landscapes of GSC dynamics in the context of a stochastically fluctuating tumor network will provide novel strategies to target resistant populations of GSCs in glioblastoma.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer stem cell; entropy; glioblastoma; heterogeneity; therapy resistance; tumor evolution

Mesh:

Substances:

Year:  2020        PMID: 32101725      PMCID: PMC8779821          DOI: 10.1016/j.trecan.2020.01.009

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  114 in total

1.  Statistical mechanics of pluripotency.

Authors:  Ben D MacArthur; Ihor R Lemischka
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

2.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

3.  L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.

Authors:  Lin Cheng; Qiulian Wu; Zhi Huang; Olga A Guryanova; Qian Huang; Weinian Shou; Jeremy N Rich; Shideng Bao
Journal:  EMBO J       Date:  2011-02-04       Impact factor: 11.598

4.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.

Authors:  J A Forsythe; B H Jiang; N V Iyer; F Agani; S W Leung; R D Koos; G L Semenza
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

5.  A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

6.  HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.

Authors:  Kelly L Covello; James Kehler; Hongwei Yu; John D Gordan; Andrew M Arsham; Cheng-Jun Hu; Patricia A Labosky; M Celeste Simon; Brian Keith
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

Review 7.  Modeling the tumor extracellular matrix: Tissue engineering tools repurposed towards new frontiers in cancer biology.

Authors:  Bartley J Gill; Jennifer L West
Journal:  J Biomech       Date:  2013-10-09       Impact factor: 2.712

8.  Targeting glioma stem cells through combined BMI1 and EZH2 inhibition.

Authors:  Xun Jin; Leo J Y Kim; Qiulian Wu; Lisa C Wallace; Briana C Prager; Tanwarat Sanvoranart; Ryan C Gimple; Xiuxing Wang; Stephen C Mack; Tyler E Miller; Ping Huang; Claudia L Valentim; Qi-Gang Zhou; Jill S Barnholtz-Sloan; Shideng Bao; Andrew E Sloan; Jeremy N Rich
Journal:  Nat Med       Date:  2017-10-09       Impact factor: 53.440

9.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

10.  Chromatin run-on and sequencing maps the transcriptional regulatory landscape of glioblastoma multiforme.

Authors:  Tinyi Chu; Edward J Rice; Gregory T Booth; H Hans Salamanca; Zhong Wang; Leighton J Core; Sharon L Longo; Robert J Corona; Lawrence S Chin; John T Lis; Hojoong Kwak; Charles G Danko
Journal:  Nat Genet       Date:  2018-10-22       Impact factor: 38.330

View more
  61 in total

Review 1.  Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment.

Authors:  Ali Karimi Sisakht; Mohammad Malekan; Farbod Ghobadinezhad; Seyedeh Negar Mousavi Firouzabadi; Ameneh Jafari; Seyed Mohammad Ali Mirazimi; Banafshe Abadi; Rana Shafabakhsh; Hamed Mirzaei
Journal:  Cell Mol Neurobiol       Date:  2022-04-11       Impact factor: 5.046

Review 2.  Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.

Authors:  Ritama Paul; Jay F Dorsey; Yi Fan
Journal:  Pharmacol Ther       Date:  2021-09-01       Impact factor: 12.310

Review 3.  Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid Tumors.

Authors:  Courtney L Jones; Anagha Inguva; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2021-03-04       Impact factor: 24.633

Review 4.  Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms.

Authors:  Wenjing Xuan; Maciej S Lesniak; Charles David James; Amy B Heimberger; Peiwen Chen
Journal:  Trends Immunol       Date:  2021-03-01       Impact factor: 16.687

5.  CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity.

Authors:  Pauliina Filppu; Jayendrakishore Tanjore Ramanathan; Kirsi J Granberg; Erika Gucciardo; Hannu Haapasalo; Kaisa Lehti; Matti Nykter; Vadim Le Joncour; Pirjo Laakkonen
Journal:  JCI Insight       Date:  2021-05-10

Review 6.  Glioblastoma Therapy: Rationale for a Mesenchymal Stem Cell-based Vehicle to Carry Recombinant Viruses.

Authors:  Sakhawat Ali; Qin Xia; Tahir Muhammad; Liqun Liu; Xinyi Meng; David Bars-Cortina; Aamir Ali Khan; Yinghui Huang; Lei Dong
Journal:  Stem Cell Rev Rep       Date:  2021-07-28       Impact factor: 5.739

Review 7.  In Vitro Glioblastoma Models: A Journey into the Third Dimension.

Authors:  Mayra Paolillo; Sergio Comincini; Sergio Schinelli
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

8.  Circumventing Drug Treatment? Intrinsic Lethal Effects of Polyethyleneimine (PEI)-Functionalized Nanoparticles on Glioblastoma Cells Cultured in Stem Cell Conditions.

Authors:  Neeraj Prabhakar; Joni Merisaari; Vadim Le Joncour; Markus Peurla; Didem Şen Karaman; Eudald Casals; Pirjo Laakkonen; Jukka Westermarck; Jessica M Rosenholm
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

Review 9.  Metabolic Drivers of Invasion in Glioblastoma.

Authors:  Joseph H Garcia; Saket Jain; Manish K Aghi
Journal:  Front Cell Dev Biol       Date:  2021-07-01

Review 10.  Genotoxic therapy and resistance mechanism in gliomas.

Authors:  Fengchao Lang; Yang Liu; Fu-Ju Chou; Chunzhang Yang
Journal:  Pharmacol Ther       Date:  2021-06-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.